Clinical Trial Update: Envafolimab Combined With GEMOX in First-line Treatment of Advanced GBC [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Envafolimab in combination with GEMOX as first-line treatment for advanced gallbladder cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gallbladder Cancer

Drugs mentioned

• Envafolimab (envafolimab)
• GEMOX (gemcitabine + oxaliplatin)

Snippet

Sponsor: Eastern Hepatobiliary Surgery Hospital | Conditions: Gallbladder Cancer | Phase 2 | Status: UNKNOWN